Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder

This study provides Class IV evidence that, in patients with DS-NMOSD, treatment with a DMT reduces relapse incidence rate ratio compared with no treatment and anti-CD20 DMTs are associated with a lower relapse incidence rate ratio compared with nonspecific immunosuppressants.

Authors

Institutions

Publication Details

Journal
Neurology Neuroimmunology & Neuroinflammation
Published
2026-02-04
DOI
https://doi.org/10.1212/nxi.0000000000200514
Citations
1
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
36.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder

Marina Solti, Emily Gibbons, Saif Masharil Huda, D. Callegaro et al.
1 citations
Neurology Neuroimmunology & Neuroinflammation
Multiple Sclerosis Research Studies
36.00
article

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder

Marina Solti, Emily Gibbons, Saif Masharil Huda, D. Callegaro, Viviane Tavares Carvalho Crelier, Jonathan D. Krett, João Vitor Mahler, Sasitorn Siritho, Natalia Drosu, Radhika Vij, Yana Said, Rebecca L. Gillani, A. H. Kim, Giovanna S. Manzano, Ekdanai Uawithya, Gerome Vallejos, Bruna Leles Vieira de Souza, Ahmetcan Sezen, Manisha Ramprasad, Olivia Pasquale, Guilherme Diogo Silva, Ilya Kister, Philippe Bilodeau, Samira Luisa Apóstolos-Pereira, Natasha Bobrowski-Khoury, Takahisa Mikami, Elias Sotirchos, Ayse Altintas, Monique Anderson, Michael Levy, Hesham Abboud, Gutemberg dos Santos, Yanjun Guo, Anu Jacob, Marcelo Matiello, Feng Gai
article en
1 citations

Abstract

This study provides Class IV evidence that, in patients with DS-NMOSD, treatment with a DMT reduces relapse incidence rate ratio compared with no treatment and anti-CD20 DMTs are associated with a lower relapse incidence rate ratio compared with nonspecific immunosuppressants.

Neurology Neuroimmunology & NeuroinflammationVol. 13(2)
Creighton University (US), Brigham and Women's Hospital (US), Beijing Tongren Hospital (CN), Siriraj Hospital (TH), Koç University (TR), Harvard University (US), Johns Hopkins University (US), University of Liverpool (GB), Universidade Federal Fluminense (BR), Capital Medical University (CN), University Hospitals of Cleveland (US), Johns Hopkins Medicine (US), Walton Centre (GB), Massachusetts General Hospital (US), Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), University School (US), New York University (US), Case Western Reserve University (US)
Good health and well-being
Openalex Percentile: Top 1%
Multiple Sclerosis Research Studies
36.00
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.